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Peritoneal Dialysis Versus Hemodialysis: A Five-year Comparison of Clinical Parameters
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Japan )
BACKGROUND: The influence of the mode of dialysis on prognosis in patients with renal disease is controversial. 
This is at least in part because of heterogeneity of patient populations, who may be receiving either continuous 
ambulatory peritoneal dialysis (CAPD) or hemodialysis (HD). In the absence of randomized trials, epidemiological 
investigations present the best method for studying the problem. METHODS: In order to determine the influence 
of the mode of dialysis on prognosis and on the cardiovascular system, erythropoiesis, and calcium metabolism, 
36 patients having CAPD and 36 patients undergoing HD were selected for study. Patients were matched based on 
age, sex, and etiology of renal disease. A 5-year follow-up study was conducted. RESULTS: Among CAPD patients 
there was 1 death due to severe infection, 1 from myocardial infarction, and 3 from congestive heart failure. In this 
group the average age were 58±3 years. Among HD patients there were 8 deaths due to congestive heart failure, 1 
from cerebrovascular accidents, and 2 due to severe, infection. In this group the average age was 63±3 years. Six 
CAPD patients were transferred to HD, because of recurrent peritonitis or elevation of serum creatinine. Patients 
on CAPD had lower blood pressures, and patients on HD had lower total cholesterol levels. Other parameters were 
not significantly different between two groups, including the doses of erythropoietin and calcium supplements 
administered. CONCLUSIONS: This study provides evidence that clinical outcomes in renal failure may depend 
to some extent upon the mode of dialysis. The results suggest that levels of blood pressure and serum total 
cholesterol should be taken into account when treating patients with either CAPD or HD, since both blood pressure 
and total cholesterol levels are likely to be important in contributing to mortality and morbidity in these patients. 
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が約 21 万人で，腹膜透析（continuous ambulatory 
peritoneal dialysis : CAPD）を施行している人が 1万
人弱である1)．世界的にみると血液透析を受けて




















































CAPD 治療群はデキストロース 1.5 g/dl もし
くは 2.5 g/dlを含む透析液を使って原則として


























～ 200 pg/mlを目標とした．iPTHが 70 pg/ml未満の
患者には炭酸カルシウム製剤を投与した．これらの薬





























































Fig. 1a and 1b. Serial changes in systolic and diastolic blood pressure in patients on CAPD and HD. In patients on CAPD, 
both systolic and diastolic blood pressure decreased significantly beginning from 2 years and lasted until 5 years compared 
to the basal values, whereas in HD only systolic blood pressure declined. The data of blood pressure were provided on the 
different condition at home (CAPD), and at office (HD). Also, the changes were significantly different between patients on 
CAPD and HD beginning from 2 years and lasted at 5 years after the start of dialysis therapy. * means p＜0.05 compared to 
basal values respectively. # means p＜0.05 compared to HD. HD:hemodialysis, CAPD:continuous ambulatory peritoneal dialysis. 
Abbreviations are the same as the following figure legends.




















Fig. 2. Serial changes in serum creatinine. The levels of 
serum creatinine increased significantly from the basal values 
at from 2 to 5 years after the start of dialysis therapy in both 
groups. There were no significant differences between two 
groups. * means p＜0.05 compared to basal values.
Fig. 3. Serial changes in serum total cholesterol. The levels 
of serum total cholesterol decreased significantly from the 
basal values at from 1 to 5 years after the start of dialysis 
therapy in CAPD group. There was significant difference from 
that in patients on HD. * * means p＜0.01 compared to basal 
values. # means p＜0.05 compared to HD.
Table 2. The serial changes of clinical parameters in the patients received HD and CAPD
*means p＜0.01 vs. basal values in each group. No significant difference was observed between HD group and CAPD group 























































































Fig. 4. Kaplan Meir-survival curve showed the time courses 
of patients who were on CAPD and on HD. There was no 






































































































 1)日本透析医学会 : わが国の慢性透析療法の現況 . 
2002; 
 2) Kurokawa K, Nangaku M, Saito A, Inagi R,  
Miyata T. Current issues and futrue perspectives of 
chronic renal failure. J Am Soc Nephrol 2002; 13: 
S3-6.
 3) Maiorca R, Cancarini GD, Camerini C, Brunori MG, 
Movilli ME, Feller P, et al. Is CAPD competitive with 
haemodialysis for long-term treatment of uraemic 
patients ? Nephrol Dial Transplant 1989; 4: 244-53.
 4) Wolfe RA, Por t FK, Har thonre VM, Guire KE. 
A comparison of survival among dialytic therapies 
of choice: in-center hemodialysis versus continuous 
ambulator y peritoneal dialysis at home. Am J 
Kidney Dis 1990; 15: 433-40.
 5) Gentil MA, Carriazo A, Pavon MI, Rosado M, 
Castillo D, Ramos B, et al. Comparison of survival 
in continuous ambulatory peritoneal dialysis and 
hospital hemodialysis: A multicentric study. Nephrol 
Dial Transplant 1991; 6: 444-51.
 6) Fenton SSA,  Schaulbel  DE,  Desmeules M, 
Morrison SI, Mao Y, Copleston P, et al. Hemodialysis 
versus peritoneal dialysis: A comparison of adjusted 
mortality rates. Am J Kidney Dis 1997; 30: 334-42.
 7) Collins AJ, Weinhandl E, Snyder JJ, Chen S-C, 
Gi lber tson D.  Comparison and sur vival  o f  
hemodialysis and peritoneal dialysis in the elderly. 
Seminars in Dialysis 2002; 15: 98-102.
 8) Burton PR, Walls J. Selection-adjusted comparison 
of life expectancy of patients on continuous 
ambulatory peritoneal dialysis, hemodialysis and 
renal transplanation. Lancet 1987; 1: 1115-9.
 9) Serkes KD, Blagg CR, Nolph KD, Venesh EF, 
Shapiro F. Comparison of patient and technique 
sur vival in continuous ambulator y peritoneal 
dialysis (CAPD) and hemodialysis; A multicenter 
study. Perit Dial Int 1989; 10: 15-9.
10)Collins AJ, Hao W, Xia H, Ebben JP, Everson SE, 
Constantini EG, et al. Mortality risks of periteonal 
dialysis and hemodialysis. Am J Kidney Dis 1999; 
34: 1065-74.
11)Bloembergen WE, Port FK, Mauger EA, Wolfe RA. 
A comparison of mortality between patients treated 
with hemodialysis and peritoneal dialysis. J Am Soc 
Nephrol 1995; 6: 177-83.
12)Gokal R. Peritoneal dialysis in the 21st century: 
an analysis of cur rent problems and future 
developments. J Am Soc Nephrol 2002; 13: S104-16.
13)Gokal R, Hutchison A. Dialysis therapies for end-
stage renal disease. Semin Dial 2002; 15: 220-6.
14)Mailloux LU, Haley WE. Hypertension in the ESRD 
patient: pathophysiology, therapy, outcomes and 
future directions. Am J Kidney Dis 1998; 32: 705-19.
15)Mazzuchi N, Carbonell E, Fernanadez-Cean J. 
I m p o r t a n c e  o f  b l o o d  p r e s s u r e  c o n t r o l  i n  
hemodialysis patient survival. Kidney Int 2000; 58: 
2147-54.
16)Cannata JB, Isels CG, Briggs JD, Junor BJR. 
Comparison of blood pressure control during 
hemodialysis and CAPD. Dial Transplant 1986; 48: 
341-5.
17)Enia G, Mallamaci F, Benedetto FA, Panuccio V, 
Parlongo S, Cutrupi S, et al. Long-term CAPD 
pat ients  are  volume expanded and display  
more severe left ventricular hyper trophy than 
haemodialysis patients. Nephrol Dial Transplant 
2001; 16: 1459-64.
18)Faller B, Lemeire N. Evolution of clinical parameters 
and peritoneal function in a cohort of CAPD patients 
followed over 7 years. Nephrol Dial Transplant 1994; 
9: 280-6.
19)Cocchi R, Degli Esposti E, Fabbri A, Lucatello A, 
Sturani A, Quarello F, et al. Prevalence of hypertension 
in patients on peritoneal dialysis: result of an Italian 
multicentre study. Nephrol Dial Transplant 1999; 14: 
1536-40.
20)Dorhout Mees EJ. Erythropoietin hypertension: fact 
or fiction ? Int J Art Org 1997; 20: 415-7.
21)Agarwal R, Lewis RR. Prediction of hypertension in 
chronic hemodialysis patients. Kidney Int 2001; 60: 
1982-9.
22)Mitra S, Chandna SM, Farrington K. What is 
hypertension in chronic haemodialysis ? The role 
of interdialytic blood pressure monitoring. Nephrol 
Dial Transplant 1999; 14: 2913-21.
23)Yarow SA, Julius S, Pickering TG. Home blood 
pressure monitoring. Arch Intern Med 2000; 160: 
1251-7.
24)Shoda J, Nakamoto H, Okada H, Suzuki H. Impact 
of introduction of continuous ambulatory peritoneal 
dialysis on blood pressure: analysis of 24-hour 
ambulatory blood pressure. Adv Perit Dial 2000; 16: 
97-101.
25)Wang MC, Tseng CC, Tsai WC, Huang JJ. Blood 
pressure and left ventricular hypertrophy in patients 
on different peritoneal dialysis regimens. Perit Dial 
Int 2001; 21: 36-42.
26)Saruta T. The Japanese new guideline for the 
220 鈴木　俊彦
management of hypertension-background of its 
preparation and characteristics of the new guideline. 
Nippon Rinsho 2001; 59: 837-40.
27)Akmal M. Hemodialysis in diabetic patients. Am J 
Kidney Dis 2001; 38(4 Suppl 1): S195-9.
28)Iseki K, Ikeyama Y, Fukiyama K. Blood pressure 
and risk of end-stage renal disease in a screened 
cohort. Kidney Int 1996; Suppl.55: S-69-S-71.
29)Por t  FK,  Hu lber t -Shear on  TE,  Wol fe  RA,  
Bloembergen WE, Golper TA, Agodoa LYC, et al. 
Predialysis blood pressure and mortality risk in 
a national sample of maintenance hemodialysis 
patients. Am J Kidney Dis 1999; 33: 507-17.
30)Oda H, Keane WF. Lipid abnormalities in end 
stage renal disease. Nephrol Dial Transplant 1998; 
Suppl:13: 45-9.
31)Kaysen GA, White M. Hyperlipidemia of chronic 
renal failure. Blood Purif 1994; 12: 60-7.
32)Kopple JD. Nutritional status as a predictor of 
morbidity and mortality in maintenance dialysis 
patients. Asaio J 1997; 43: 246-50.
33)Sezer S, Ozdemir FN, Arat Z, Perim O, Turan M, 
Haberal M. The association of interdialytic weight 
gain with nutritional parameters and mortality risk 
in hemodialysis patients. Ren Fail 2002; 24: 37-48.
34)Fung F,  Sher rar d  DJ ,  Gi l len  DL,  Wong C,  
Kestenbaum B, Seliger S, et al. Increased risk for 
cardiovascular mortality among malnourished end-
stage renal disease patients. Am J Kidney Dis 2002; 
40: 307-14.
35)Mittman N, Avram MM, Oo KK, Chattopadhyay J. 
Serum prealbumin predicts survival in hemodialysis 
and peritoneal dialysis: 10 years of prospective 
observation. Am J Kidney Dis 2001; 38: 1358-64.
© 2002 The Medical Society of Saitama Medical School
